All Viruses articles – Page 5
-
NewsFrom Miami to Berlin: stowaway rat delivers valuable pathogen lessons
in 2017, a Miami–Berlin flight took an unexpected turn when passengers spotted a rat on board. The incident underscored how easily pathogens can spread across continents—and why standardized testing of animal stowaways is so important.
-
NewsResearchers uncover how COVID-19 may linger in cancer patients and affect treatment outcomes
New research is providing important insights into how COVID-19 persists in cancer patients even long after testing positive. Researchers studied three cancer patients who had undergone transplant therapies and were hospitalized with severe COVID-19 infections.
-
NewsScientists report the first use of CRISPR activation to treat a cardiac disease in mice
Researchers have demonstrated for the first time that CRISPR-based gene activation (CRISPRa) can be used to treat genetic heart disease in vivo. The study paves the way for novel targeted therapies for patients with genetic cardiac disorders.
-
NewsA ‘universal’ therapy against the seasonal flu? Antibody cocktail targets virus weak spot
Researchers report that a cocktail of antibodies protected mice—including those with weakened immune systems—from nearly every strain of influenza tested, including avian and swine variants that pose pandemic threats.
-
News‘Microbial piracy’ uncovers new way to fight drug-resistant infections
Researchers have discovered how ‘pirate phages’ hijack other viruses to break into bacteria, sharing new genetic material for dangerous traits.
-
NewsNovel Bocaparvovirus identified in goats in China
Researchers identified a novel Bocaparvovirus in goat fecal samples using metagenomic techniques, with detection in goats from 3 regions in China: Sichuan, Hunan and Chongqing.
-
NewsPediatric investigation study re-examines chikungunya in neglected pediatric victims
Researchers and policymakers must recalibrate their outlook on pediatric chikungunya to develop effective control measures, a new paper warns.
-
NewsWarming climate drives disease surge, study shows
Projections suggest future warming could raise dengue incidence by 49%–76%, depending on emissions scenarios, if other factors remain constant. Cooler areas are expected to see the biggest increases, while hotter locations may experience slight declines.
-
NewsMushroom chemical teams with phages to deliver a one-two punch to MRSA
A chemical found in mushrooms can be teamed with bacteriophages to deliver a one-two punch to antibiotic-resistant infections, reveals a study presented at MLS Future Forum 2025.
-
NewsBlood test identifies HPV-associated head and neck cancers up to 10 years before symptoms
Researchers show that a novel liquid biopsy tool called HPV-DeepSeek can identify HPV-associated head and neck cancer up to 10 years before symptoms appear.
-
NewsEven healthy children can be severely affected by RSV
It is not only premature babies and children with underlying diseases who suffer from serious respiratory syncytial virus (RSV) infections. Even healthy, full-term babies are at significant risk of intensive care or prolonged hospitalisation – especially during the first three months of life.
-
NewsStudy reveals how dengue rewires the immune system, reshaping vaccine response
Just as a computer’s operating system can be rewritten after a major update, dengue infection can ‘re-programme’ the body’s immune system, leaving a long-lasting genetic imprint that influences how people respond to future infections—an effect not seen with vaccination.
-
NewsScientists unveil viral mechanism behind nasopharyngeal cancer spread
Researchers have discovered that the Epstein-Barr virus (EBV), a common human virus closely linked to nasopharyngeal carcinoma (NPC), can change the 3D structure of the human genome inside cancer cells, much like assembling building blocks.
-
NewsA survival kit for smallpox viruses
Scientists have discovered a previously unknown type of assembly chaperone during their analysis of poxviruses, and they have decoded its function in full detail. This is the first known chaperone that is not formed by a protein but by a nucleic acid — specifically RNA.
-
NewsResearchers map key human proteins that power coronavirus replication, pointing to new treatment strategies
Scientists have pinpointed dozens of human proteins that SARS-CoV-2 needs to complete its full life cycle, from entering a cell to replicating and releasing new viral particles.
-
NewsGray seals perplex scientists with lack of response to flu infection
Something strange happens when two kinds of seals living in the waters around Cape Cod get infected with influenza – harbor seals get sick but gray seals don’t. This perplexing phenomenon led scientists to investigate if a difference in a piece of the immune system called cytokines could be responsible for this difference.
-
NewsProtein discovery gives new hope for longer COVID protection
Scientists have discovered that the body’s immune system strongly reacts to an internal protein from SARS-CoV-2, the virus that causes COVID-19, which mutates less frequently than the surface-spike protein currently targeted by vaccines.
-
NewsAntibody-making cells reveal new function in response to flu infection
A study has uncovered a new function of the immune cells that are known for making antibodies. Researchers determined that, in response to flu infection, a specialized set of B cells produce a key signaling molecule that the immune system needs to develop a robust, long-term response to fight off infections.
-
NewsInfectious disease modelling teams invited to strengthen global response to highly pathogenic avian influenza
An international modelling challenge is calling on experts across disciplines to help tackle one of Europe’s most pressing health threats: highly pathogenic avian influenza (HPAI). The initiative, which is now open for applications, seeks to improve outbreak modelling readiness and to foster international collaboration among researchers and decision makers.
-
NewsCARB-X to support lower respiratory tract infection diagnostic by Zeteo
CARB-X has awarded Zeteo Tech, Inc. US$1M to execute a workplan for its noninvasive diagnostic platform that aims to evaluate whether exhaled breath can diagnose lower respiratory tract infections (LRTIs) in high-risk populations within critical care environments.